Navigation Links
Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
Date:10/1/2013

BEDFORD, Mass., Oct. 1, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that Jack W. Cumming, Hologic's President and Chief Executive Officer, will preside over the NASDAQ Stock Market Opening Bell Ceremony marking the start of a month long effort to raise awareness of breast cancer and the importance of breast cancer screening. This is the eighth year that Hologic has been selected to participate in the NASDAQ opening bell ceremonies celebrating the start of Breast Cancer Awareness Month.

In his opening remarks, Mr. Cumming will focus on the value of Hologic's 3D mammography (breast tomosynthesis) in finding more invasive cancers and decreasing unnecessary recalls.Hologic's 3D Mammography Technology3D mammography (breast tomosynthesis) technology detects invasive cancers earlier when the disease is easiest to treat. Unlike conventional 2D mammography where the presence of overlapping breast tissue can make it more difficult to detect cancer, Hologic's 3D mammography technology is designed to allow doctors to see the breast more clearly, particularly for women with dense breasts.  As a result, fewer women are called back for additional testing due to false positive results. Large clinical studies in Europe and the U.S. report that Hologic's 3D mammography technology significantly reduces recall rates while simultaneously improving cancer detection.

  • Clinical research shows that the Hologic 3D mammogram finds 40% more invasive cancers than conventional 2D mammography.
  • Clearer, more detailed images from the Hologic 3D mammogram give doctors the confidence to significantly reduce recall rates by up to 40%, minimizing the inconvenience, cost and anxiety that women feel when asked to return for unnecessary follow-up tests.
  • Hologic is the only manufacturer to receive FDA approval for 3D mammography and is the largest breast tomosynthesis vendor worldwide. More than 3 million women will be screened this year with this groundbreaking technology.

    Webcast Information:The Hologic NASDAQ Stock Market Opening Bell Ceremony will be aired live at http://www.nasdaq.com/reference/marketsite_about.aspx (access this by clicking on the MarketSite live webcam) and will also be aired with closed captioning on the NASDAQ MarketSite Tower in Times Square. A video of the Opening Bell ceremony will be archived for one year on the NASDAQ site.

    About Hologic, Inc.:Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on breast health, diagnostics, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.

    Hologic and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

    Forward-Looking Statement Disclaimer:This News Release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic digital mammography systems. There can be no assurance the systems will achieve the benefits described herein and that such benefits will be replicated in any particular manner with respect to an individual patient as the actual effect of the use of the systems can only be determined on a case-by-case basis depending on the particular circumstances and patient in question. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based.

    Investor and Media Contacts:Deborah R. Gordon

    Marianne McMorrowVice President, Investor Relations

    Global PR and Advertising Publicist (781) 999-7716

    (781) 999-7723deborah.gordon@hologic.com 

    marianne.mcmorrow@hologic.comAl Kildani Senior Director, Investor Relations (858) 410-8653 al.kildani@hologic.com 


    '/>"/>
    SOURCE Hologic, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Hologic to Present at Two Upcoming Investor Conferences
    2. Hologic Announces Third Quarter Fiscal 2013 Operating Results
    3. Hologic Announces Completion of Term Loan B Repricing
    4. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
    5. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
    6. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
    7. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
    8. Quest Diagnostics and Hologic Form Strategic Alliance to Improve Womens Health
    9. Hologic riceve lapprovazione FDA per una nuova soluzione di mammografia 3D (tomosintesi al seno) a bassa dose per lo screening del tumore al seno
    10. Hologic erhält FDA-Zulassung für eine neue niedrigdosierte 3D-Mammographie-Lösung (Brust-Tomosynthese) für Brustkrebs-Screening
    11. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
    (Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
    (Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
    (Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
    (Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
    (Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
    (Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
    Breaking Medicine News(10 mins):